These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 10102060)

  • 1. When and how to combine growth hormone with a luteinizing hormone-releasing hormone analogue.
    Tanaka T; Satoh M; Yasunaga T; Horikawa R; Tanae A; Katsumata N; Tachibana K; Nose O; Hibi I
    Acta Paediatr Suppl; 1999 Feb; 88(428):85-8. PubMed ID: 10102060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GH and GnRH analog treatment in children who enter puberty at short stature.
    Tanaka T; Satoh M; Yasunaga T; Horikawa R; Tanae A; Hibi I
    J Pediatr Endocrinol Metab; 1997; 10(6):623-8. PubMed ID: 9467133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial.
    Mericq MV; Eggers M; Avila A; Cutler GB; Cassorla F
    J Clin Endocrinol Metab; 2000 Feb; 85(2):569-73. PubMed ID: 10690857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa.
    van der Steen M; Lem AJ; van der Kaay DC; Hokken-Koèelega AC
    J Clin Endocrinol Metab; 2016 May; 101(5):2005-12. PubMed ID: 26964733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency.
    Reiter EO; Lindberg A; Ranke MB; Price DA; Albertsson-Wikland K; Cowell CT; Bakker B
    Horm Res; 2003; 60(Suppl 1):68-73. PubMed ID: 12955021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors determining pubertal growth and final height in growth hormone treatment of idiopathic growth hormone deficiency. Analysis of 195 Patients of the Kabi Pharmacia International Growth Study.
    Ranke MB; Price DA; Albertsson-Wikland K; Maes M; Lindberg A
    Horm Res; 1997; 48(2):62-71. PubMed ID: 9251922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of bone age maturation and growth velocity in isolated growth hormone (GH) deficient boys with and without gonadal suppression treatment and in GH deficient boys with associated gonadotropin deficiency.
    Satoh M; Tanaka T; Hibi I
    J Pediatr Endocrinol Metab; 1997; 10(6):615-22. PubMed ID: 9467132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Beneficial Effect of Combined GH/GnRHa Therapy in Increasing Adult Height Outcome in Children With ISS.
    Lazar L; Levy S; Oron T; Meyerovitch J; de Vries L; Shalitin S; Tenenbaum A; Phillip M; Lebenthal Y
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3287-3295. PubMed ID: 30912806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth response, pubertal growth and final height in Greek children with growth hormone (GH) deficiency on long-term GH therapy and factors affecting outcome.
    Karavanaki K; Kontaxaki C; Maniati-Christidi M; Petrou V; Dacou-Voutetakis C
    J Pediatr Endocrinol Metab; 2001 Apr; 14(4):397-405. PubMed ID: 11327373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone (GH)-treated GH-deficient children.
    Hibi I; Tanaka T; Tanae A; Kagawa J; Hashimoto N; Yoshizawa A; Shizume K
    J Clin Endocrinol Metab; 1989 Aug; 69(2):221-6. PubMed ID: 2526818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
    Cara JF; Kreiter ML; Rosenfield RL
    J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined GH and LHRH analog treatment in short children.
    Tanaka T; Satoh M; Hibi I
    Endocr J; 1996 Oct; 43 Suppl():S13-7. PubMed ID: 9076337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with GH and cyproterone acetate does not improve final height in boys with non-GH-deficient short stature.
    Kawai M; Momoi T; Yorifuji T; Muroi J; Yamanaka C; Sasaki H; Furusho K
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):53-7. PubMed ID: 9509068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimens.
    Albertsson Wikland K; Alm F; Aronsson S; Gustafsson J; Hagenäs L; Häger A; Ivarsson S; Kriström B; Marcus C; Moëll C; Nilsson KO; Ritzén M; Tuvemo T; Westgren U; Westphal O; Aman J
    Acta Paediatr Suppl; 1999 Feb; 88(428):80-4. PubMed ID: 10102059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of treatment with GH alone or in combination with LHRH analog on bone mineral density in pubertal GH-deficient patients.
    Mericq V; Gajardo H; Eggers M; Avila A; Cassorla F
    J Clin Endocrinol Metab; 2002 Jan; 87(1):84-9. PubMed ID: 11788628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.